Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 4
1 (50.0%)Clinical Study of Cardiomyopeptidin on Postoperative Ischemia-reperfusion Injury in Patients With Primary PCI
Phase 4
- Conditions
- Left Ventricular Ejection FractionSurvival Myocardial Area After Acute Myocardial Death
- Interventions
- First Posted Date
- 2019-05-22
- Last Posted Date
- 2019-05-22
- Lead Sponsor
- Dalian Zhen-Ao Bio-Tech Co., Ltd.
- Target Recruit Count
- 160
- Registration Number
- NCT03958422
Phase IIaTrials of GanMaoKangNing Granules
Phase 2
- Conditions
- Epidemic Influenza
- Interventions
- Drug: GanMaoKangNing GranulesDrug: Analogous GanMaoKangNing Granules
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2016-12-12
- Lead Sponsor
- Dalian Zhen-Ao Bio-Tech Co., Ltd.
- Target Recruit Count
- 96
- Registration Number
- NCT02989012
- Locations
- 🇨🇳
Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing Shi, Beijing, China
News
No news found